Not exact matches
Whole
brain radiotherapy (WBRT) significantly improves tumor control in the
brain after SRS, yet
because of its association with cognitive decline, its role in the treatment of patients with
brain metastases remains controversial.
Central nervous system (CNS) tumors pose a particular challenge for antibody therapeutics,
because the blood -
brain barrier (BBB) prevents intravenously - injected antibodies from reaching CNS
metastases.